FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

6/29/2017
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   6/29/2017     P    2000   A $0.0396   21367349   D    
Common Stock   6/29/2017     P    1000   A $0.0419   21368349   D    
Common Stock   6/29/2017     P    1000   A $0.0415   21369349   D    
Common Stock   6/29/2017     P    1000   A $0.0419   21370349   D    
Common Stock   6/29/2017     P    1000   A $0.0419   21371349   D    
Common Stock   6/29/2017     P    1000   A $0.0419   21372349   D    
Common Stock   6/29/2017     P    1000   A $0.042   21373349   D    
Common Stock   6/29/2017     P    1000   A $0.0419   21374349   D    
Common Stock   6/29/2017     P    2000   A $0.038   21376349   D    
Common Stock   6/29/2017     P    1000   A $0.038   21377349   D    
Common Stock   6/29/2017     P    1000   A $0.038   21378349   D    
Common Stock   6/29/2017     P    1000   A $0.0365   21379349   D    
Common Stock   6/29/2017     P    1000   A $0.034   21380349   D    
Common Stock   6/29/2017     P    10000   A $0.0342   21390349   D    
Common Stock   6/29/2017     P    1000   A $0.0365   21391349   D    
Common Stock   6/29/2017     P    1000   A $0.0365   21392349   D    
Common Stock   6/29/2017     P    1000   A $0.0357   21393349   D    
Common Stock   6/29/2017     P    1000   A $0.0377   21394349   D    
Common Stock   6/29/2017     P    1000   A $0.0379   21395349   D    
Common Stock   6/29/2017     P    1000   A $0.0379   21396349   D    
Common Stock   6/29/2017     P    1000   A $0.0379   21397349   D    
Common Stock   6/29/2017     P    1000   A $0.0379   21398349   D    
Common Stock   6/29/2017     P    1000   A $0.0376   21399349   D    
Common Stock   6/29/2017     P    1000   A $0.0379   21400349   D    
Common Stock   6/29/2017     P    1000   A $0.0379   21401349   D    
Common Stock   6/29/2017     P    1000   A $0.0372   21402349   D    
Common Stock   6/29/2017     P    1000   A $0.0375   21403349   D    
Common Stock   6/30/2017     P    2000   A $0.0266   21405349   D    
Common Stock   6/30/2017     P    1000   A $0.027   21406349   D    
Common Stock   6/30/2017     P    2000   A $0.027   21408349   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Mann 7/5/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.